輸入代號或公司名稱後按 Enter
3176

基亞

-0.20 (-0.53%)最後更新 2026-09-16
台灣 · 上櫃 · 生技醫療業
37.85688成交張數本益比3.59股價淨值比0.00%殖利率2026-09-16資料日期

綜合損益表公開資訊觀測站申報原值 · 年度(第 4 季累計) · 每一格 = 該科目 ÷ 營業收入

營業收入20251,583年增 +15.3%
毛利率202557.2%最新一期
營業利益率2025-9.9%最新一期
每股盈餘2025-0.78
會計項目走勢2016201720182019202020212022202320242025
營業收入合計100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%
營業成本合計73.3%65.8%70.7%53.6%57.2%34.9%91.7%46.7%45.1%42.8%
營業毛利(毛損)26.7%34.2%29.3%46.4%42.8%65.1%8.3%53.3%54.9%57.2%
未實現銷貨(損)益0.2%0.0%3.0%
營業毛利(毛損)淨額26.7%34.2%29.3%46.4%42.6%65.1%8.3%53.3%54.9%54.2%
推銷費用27.1%24.8%22.7%15.2%15.6%2.4%15.2%21.8%23.7%19.5%
管理費用69.4%55.8%49.9%35.5%39.9%7.2%22.9%21.4%17.9%15.8%
研究發展費用117.7%110.7%143.9%126.4%135.9%35.9%126.0%115.4%28.6%28.6%
預期信用減損損失(利益)-0.0%7.2%-0.5%-0.5%2.0%1.2%0.5%0.3%
營業費用合計214.3%191.2%216.5%184.4%190.8%45.0%166.1%159.8%70.7%64.1%
營業利益(損失)-187.6%-157.0%-187.2%-138.0%-148.2%20.1%-157.9%-106.5%-15.8%-9.9%
利息收入0.4%0.1%0.8%7.7%3.8%2.2%
其他收入11.3%13.9%3.1%25.8%14.8%11.4%7.2%2.2%0.5%0.6%
其他利益及損失淨額-54.4%-23.0%-2.8%-19.6%4.1%0.4%1.1%-1.0%8.0%-2.5%
財務成本淨額2.7%4.1%5.7%5.7%5.2%0.5%3.7%4.8%2.7%1.5%
採用權益法認列之關聯企業及合資損益之份額淨額-10.5%-8.9%-2.5%-24.8%-8.0%-2.1%-2.7%
營業外收入及支出合計-45.8%-13.2%-5.4%-10.0%5.2%8.9%-19.5%-4.0%7.6%-3.9%
稅前淨利(淨損)-233.4%-170.2%-192.6%-148.1%-143.0%29.0%-177.3%-110.5%-8.2%-13.8%
所得稅費用(利益)合計-10.2%-0.1%3.9%1.6%-5.3%1.7%5.6%16.5%8.0%4.9%
繼續營業單位本期淨利(淨損)-223.2%-170.1%-196.5%-149.6%-137.7%27.3%-182.9%-127.0%-16.2%-18.7%
本期淨利(淨損)-223.2%-170.1%-208.0%-124.6%-137.7%27.3%-182.9%-127.0%-16.2%-18.7%
確定福利計畫之再衡量數0.1%0.6%0.7%0.1%-0.5%-0.0%-0.1%-0.0%0.2%-0.0%
透過其他綜合損益按公允價值衡量之權益工具投資未實現評價損益1.9%11.9%-10.4%-0.5%7.8%0.0%6.1%-9.8%
與不重分類之項目相關之所得稅0.0%0.1%0.4%0.2%-1.2%-0.1%-0.0%-0.0%0.0%-0.0%
不重分類至損益之項目:11.8%-9.7%-0.5%7.7%-0.0%6.3%-9.8%
國外營運機構財務報表換算之兌換差額-0.9%-0.5%-0.3%-0.5%0.5%-0.3%-0.1%1.5%-0.2%0.0%
採用權益法認列之關聯企業及合資之其他綜合損益之份額-可能重分類至損益之項目0.0%0.2%0.1%
與可能重分類之項目相關之所得稅0.3%-0.4%-0.1%-0.1%0.1%-0.0%-0.0%0.2%0.0%0.0%
後續可能重分類至損益之項目:-0.4%0.4%-0.3%-0.1%1.4%-0.1%0.1%
其他綜合損益(淨額)1.3%-1.5%2.0%11.4%-9.3%-0.8%7.6%1.4%6.3%-9.7%
本期綜合損益總額-221.9%-171.6%-206.0%-113.1%-147.0%26.5%-175.3%-125.6%-9.9%-28.4%
母公司業主(淨利∕損)-142.1%-102.0%-108.7%-46.3%-54.9%-1.3%-64.0%-48.5%-14.9%-6.9%
非控制權益(淨利∕損)-81.1%-68.2%-99.4%-78.3%-82.8%28.6%-118.9%-78.5%-1.3%-11.8%
母公司業主(綜合損益)-140.8%-103.4%-106.7%-34.9%-58.9%-1.7%-62.4%-47.9%-12.7%-10.4%
非控制權益(綜合損益)-81.1%-68.2%-99.4%-78.3%-88.1%28.2%-112.9%-77.7%2.8%-18.0%
基本每股盈餘-1.0%-0.7%-0.8%-0.3%-0.4%-0.0%-0.5%-0.3%-0.1%-0.0%
已實現銷貨(損)益0.0%0.0%
繼續營業單位淨利(淨損)-0.0%-0.0%-0.0%-0.0%-0.0%-0.0%-0.0%
停業單位損益合計-11.5%25.1%0.0%
停業單位淨利(淨損)-0.0%0.0%0.0%
備供出售金融資產未實現評價損益2.4%-1.9%0.0%
稀釋每股盈餘-1.0%-0.7%-0.8%

金額為公司申報原值除以一千(百萬元,四捨五入),每股金額為元。年度為第 4 季的年初至今累計數。走勢條是歷史各期的相對大小,藍為正、綠為負。年增以去年同期為基期,基期非正數或變動超過十倍時不列。 權益變動表在申報資料分頁。